ADC THERAPEUTICS — 2141279
Application number
2141279
Registration number
TMA1315761
International Registration Number
1621298
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2021-05-03
International Registration
2021-05-03
Registered
2025-05-23
Registration Expiry Date
2031-05-03
Registered Owner
ADC Therapeutics SA
Route de la Corniche, 3B
CH-1066 Epalinges
SWITZERLAND
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Trademark description
The mark consists of the letters ADC above the word THERAPEUTICS; a wave element extends across the letter A to a shared edge of the letters D and C.
Index headings
- ADC THERAPEUTICS
- AD
- A
- D
Vienna information (Code & Description)
- 26.11.1
- One line or one band
- A 26.11.6
- Thick lines, bands
- A 26.11.8
- Horizontal lines or bands
- A 26.11.13
- Wavy lines or bands, zigzag lines or bands
- 27.5.1
- Letters presenting a special form of writing
- A 27.5.11
- Letters underlined, overlined, framed or barred by one or more strokes
- A 27.5.8
- Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.
- A 27.5.22
- Monograms formed of intertwined, overlapping or otherwise combined letters
- 25.12.3
- Moiré surfaces or backgrounds
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for use in the prevention and treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, inflammatory, immune, autoimmune, genetic, and rare oncological, immune, autoimmune, and genetic diseases, disorders, and conditions; anti-infectives, pharmaceutical preparations for human use, namely, pharmaceutical antibodies, pharmaceutical preparations for use in immunotherapies, pharmaceutical preparations, biological preparations, and gene therapy products in the nature of pharmaceutical and biological substances for the treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions, pharmaceutical preparations made from antibody-drug conjugates for conditioning patients to receive immunotherapies for the treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions; pharmaceutical preparations for use in the prevention and treatment of cancer and tumors.
Services (Nice class & Statement)
- 42
- (1) Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals.
- 44
- (2) Providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health.
Claims
- Priority Filing Date: November 05, 2020, Country or Office: UNITED STATES OF AMERICA, Application No. 90301364 in association with the same kind of goods and in association with the same kind of services
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2021-05-03 | Registration | |
| International Registration | 2021-05-03 | 2031-05-03 | |
| Created | 2021-10-20 | ||
| Formalized | 2021-10-20 | ||
| Designation Notification - Madrid Protocol | 2021-10-21 | 2023-04-21 | |
| Notification of Possible Opposition Sent | 2022-08-22 | ||
| Search Recorded | 2023-01-26 | ||
| Examiner's First Report | 2023-01-26 | 2023-07-26 | |
| Total Provisional Refusal | 2023-01-26 | 2023-07-26 | |
| Agent Changed | 2023-07-24 | From/De: To/A: 69 | |
| Correspondence Created | 2024-01-09 | 2024-07-09 | |
| Approved | 2025-02-06 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-02-06 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-03-05 | Vol.72 Issue 3671 | |
| Opposition Start Date Notice Sent | 2025-03-05 | Requested on 2025/03/05 00:30:05 in program jr500m1 | |
| Registration Pending | 2025-05-23 | ||
| Registered | 2025-05-23 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2025-05-23 | ||
| Partial Cancellation - Madrid Protocol | 2026-04-09 | DP:2026-04-29 Effective date: 2026-02-26 |